6Mizock BA. Alterations in fuel metabolism in critical illness: hy- perglycemia[J]. Best Pract Res Clin Endoerinol Metab, 2001, 15 (4) : 533-551.
7Warwick D, Harrison J, Whitehouse S, et al. A randomized comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement [J].J Bone Joint Surg Br, 2002, 84(3) :344-350.
5Cronell CN. Management of fracture in patients with osteoporosis [J]. Orthop Clin North Am, 1990; 21 ( 7 ) : 125 -41.
6Warwick D, Harrison J, Whitehouze S ,et al. A randomized comparison of a foot pump and low-molecular-weight heparin in the prevention of deepvein thrombosis after total knee replacement[J]. J Bone Joint Surg Br,2002;84(406) :344-51.
7Cummings SR,Melton LJ.Epidemiology and outcomes of osteoporotic fractures[J].Lancet,2002,359:1761.
8Lawrence VA,Hilsenbeck SG,Noveck H,et al.Medical complication and outcomes after hip fracture repair[J].Arch Intem Med,2002,162(18):2053.
9Casaletto JA,Gatt R,Injury.Post-operative mortality related to waiting time for hip fracture[J].Surgery,2004,35(2):114.
10Gdalevich M,Cohen D,Yosef D,et al.Morbidity and mortality after hip fracture:the impact of operative dealy[J].Arch Orthop Trauma Surg,2004,124 (5):334.
